Cytomegalovirus in hematopoietic stem cell transplant recipients

Per Ljungman; Morgan Hakki; Michael Boeckh

doi:10.1016/j.hoc.2010.11.011

Cytomegalovirus in hematopoietic stem cell transplant recipients

Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011.

Authors

Per Ljungman¹, Morgan Hakki, Michael Boeckh

Affiliation

¹ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

Abstract

This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

Abstract

Grants and funding